HocusLocus, LLC

We save drug companies billions of dollars in biomanufacturing costs through a new technique for cell line development that is easily adopted and high margin.

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Albany, NY, USA
  • Currency USD
  • Founded May 2011
  • Employees 4
  • Incorporation Type LLC
  • Website hocuslocus.com

Company Summary

We have developed a novel cell selection protocol based on post-transcriptional regulation that we call PTSelect. PTSelect eliminates the need for antibiotics to perform selection and replaces them with an siRNA and performs selection with transfected mRNA. PTSelect can save biological drug manufacturers billions of dollars by increasing the yield of their drug in any cell line because cells only make the drug and no other proteins.



  • Goodwin Procter

Previous Investors

  • Eastern New York Angels

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free